What is the recommended starting dose of norepinephrine for an adult (70 kg) patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Starting Dose of Norepinephrine

For a 70 kg adult patient, start norepinephrine at 0.1-0.5 mcg/kg/min (7-35 mcg/min), which translates to approximately 0.05 mcg/kg/min as a practical initial dose, then titrate rapidly to achieve a mean arterial pressure (MAP) of 60-65 mmHg. 1, 2

Dosing Algorithm

Initial Dose Selection

  • Standard starting range: 0.1-0.5 mcg/kg/min (7-35 mcg/min for 70 kg adult) 1
  • FDA-approved approach: Start with 2-3 mL/min of a 4 mcg/mL solution (8-12 mcg/min), then titrate 2
  • Practical starting dose: 0.05 mcg/kg/min appears optimal based on recent evidence, as lower doses (0.025 mcg/kg/min) may be insufficient to achieve target MAP within 60 minutes in patients with severe hypotension 3

Titration Strategy

  • Target MAP: 60-65 mmHg is recommended over higher targets 4
  • Maintenance range: 0.5-1 mL/min (2-4 mcg/min) for most patients 2
  • Maximum doses: Can escalate to 0.20 mcg/kg/min or higher if needed, though doses as high as 68 mg/day have been reported in refractory cases 2, 5
  • Titrate to effect: Adjust based on blood pressure response and tissue perfusion, not just MAP targets 2

Critical Considerations

Baseline Hypotension Severity Matters

Recent evidence demonstrates that initial MAP predicts dose requirements: patients with MAP <50 mmHg may fail to reach target MAP within 60 minutes at lower starting doses (0.025-0.050 mcg/kg/min) 3. This supports starting at the higher end of the recommended range (0.1 mcg/kg/min or approximately 7 mcg/min for 70 kg) in severely hypotensive patients.

Weight-Based vs Non-Weight-Based Dosing

A 2023 study found that weight-based dosing resulted in lower total norepinephrine requirements while achieving similar MAP targets compared to non-weight-based dosing 6. This supports using mcg/kg/min rather than fixed mcg/min dosing.

Administration Route

  • Central line preferred: Norepinephrine can cause tissue necrosis with extravasation 1, 2
  • Large vein acceptable: Antecubital vein is acceptable if central access unavailable 2
  • Avoid leg veins: Particularly in elderly or those with vascular disease due to gangrene risk 2

Preparation and Compatibility

  • Standard dilution: 4 mg in 1000 mL of 5% dextrose = 4 mcg/mL 2
  • Must use dextrose-containing solutions: Protects against oxidation and potency loss 2
  • Never mix with alkaline solutions: Sodium bicarbonate inactivates catecholamines 1

Common Pitfalls

Starting Too Low

The most significant pitfall is starting at inadequate doses in severely hypotensive patients. Evidence shows that failure to achieve MAP ≥65 mmHg within 60 minutes is independently associated with increased ICU mortality (OR 1.49) 3. Don't be timid—start at 0.1 mcg/kg/min (7 mcg/min) in severe shock.

Delaying Adequate Fluid Resuscitation

Blood volume depletion must be corrected before or concurrent with norepinephrine 2. Norepinephrine is relatively contraindicated in hypovolemia 1. If hypotension persists despite adequate norepinephrine, suspect occult volume depletion 2.

Extravasation Management

If extravasation occurs, immediately infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline into the affected area 1. Monitor infusion sites frequently for blanching, which may indicate vasa vasorum constriction even without obvious extravasation 2.

Ignoring Underlying Conditions

  • Ischemic heart disease: Use cautiously as norepinephrine increases myocardial oxygen demand 1
  • MAOI or tricyclic antidepressants: Severe prolonged hypertension may result; use extreme caution 2
  • Cyclopropane/halothane anesthesia: Generally contraindicated due to arrhythmia risk 2

Special Populations

Septic Shock

In sepsis, norepinephrine is the first-line vasopressor 4, 7. Interestingly, while norepinephrine typically causes renal vasoconstriction, in septic shock it improves renal blood flow and urine output 1. Studies show creatinine clearance increased from 73 to 114 mL/min after 48 hours of norepinephrine therapy in septic patients 7.

Anesthesia Context

Under general anesthesia, the dose-response relationship changes dramatically. A 2025 study found the slope of the dose-MAP relationship more than doubles during anesthesia (from 103 to 222 mmHg per mcg/kg/min) 5. The practical equation for anesthetized patients: required dose = (target MAP - 54)/222 mcg/kg/min 5.

Hepatorenal Syndrome

When used outside the ICU for hepatorenal syndrome, norepinephrine can be started at 5 mcg/min with a goal to increase MAP by 10 mmHg above baseline, achieving 45% response rates in patients who failed midodrine/octreotide 8.

When to Add Second-Line Agents

If target MAP cannot be achieved with norepinephrine alone, add vasopressin as a second-line agent rather than continuing to escalate norepinephrine 4. This strategy may reduce catecholamine-related adverse effects while maintaining hemodynamic stability 9.

References

8
Research

Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021

Related Questions

How should a double‑strength norepinephrine infusion be initially started?
What is the appropriate preparation, initial dosing, and titration protocol for starting a norepinephrine (noradrenaline) infusion in a 50 kg patient?
In a 65-year-old woman with diabetes mellitus and a remote myocardial infarction who is in septic shock from urosepsis, receiving norepinephrine, remains hypoxic despite 100% FiO₂, has bilateral lung infiltrates on chest X‑ray, and pulmonary artery catheter data showing low right atrial pressure, low pulmonary artery pressure, low pulmonary capillary wedge pressure, and normal cardiac output, what is the most likely cause of the bilateral lung infiltrates?
Should vasopressin be added when norepinephrine is at 15 µg/min to maintain target mean arterial pressure?
How should norepinephrine (noradrenaline) be prescribed as an intravenous continuous infusion for an adult patient with hypotension or shock?
How should cough be managed in an end-stage renal disease patient on hemodialysis?
In a hemodialysis patient presenting with a dry cough, what are the likely causes and recommended evaluation and management steps?
How should a dry (non‑productive) cough be evaluated and managed?
In a pediatric emergency department, how should a child with suspected vasculitis—presenting with fever and a new purpuric rash, persistent abdominal pain, arthralgia, edema, hypertension, hematuria, or neurologic signs—be evaluated and worked up?
If a quantitative HBV DNA test is unavailable, what alternative methods can be used to determine hepatitis B virus (HBV) viral load?
When is it appropriate to initiate fractional CO₂ laser therapy for scar treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.